Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00819208 · ClinicalTrials.gov registry record · NA

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

A NA study of Depression and Colorectal Cancer, sponsored by Canadian Cancer Trials Group.

Active
Registry status
NA
Development phase
889
Enrollment target
20
Study locations

NCT00819208 is a NA study of Depression and Colorectal Cancer that is active but no longer recruiting, run by Canadian Cancer Trials Group. The registered enrollment target is 889 participants, above the 785-participant average among 679 other Depression trials with a reported enrollment target (13% higher). The trial reports 20 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00819208, a NA study of Depression and Colorectal Cancer, is active but no longer recruiting, sponsored by Canadian Cancer Trials Group.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
889 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Participating in a physical activity program designed to increase free time physical activity and receiving written health education materials may influence the chance of cancer recurring as well as impact on physical fitness, psychological well-being and the quality of life of patients who have undergone surgery and chemotherapy for colon cancer. It is not yet known whether giving a physical activity program together with health education materials is more effective than giving health education materials alone for patients who have undergone colon cancer treatment. PURPOSE: This randomized phase III trial is studying a physical activity program given together with health education materials to see how well it works compared with giving health education materials alone for patients who have undergone treatment for high-risk stage II or stage III colon cancer.

Interventions

  • BEHAVIORAL exercise intervention
  • OTHER counseling intervention
  • OTHER educational intervention
  • OTHER laboratory biomarker analysis
  • OTHER questionnaire administration

Study Locations (20)

New South Wales

  • Armidale Hospital - Armidale
  • Bankstown-Lidcombe Hospital - Bankstown
  • Royal Prince Alfred Hospital - Camperdown
  • North Coast Cancer Institute Coffs Harbour - Coffs Harbour
  • Concord Repatriation General Hospital - Concord
  • Liverpool Hospital - Liverpool
  • Newcastle Private Hospital - Newcastle
  • North Coast Cancer Institute - Port Macquarie - Port Macquarie
  • Royal North Shore Hospital - St Leonards
  • Tamworth Hospital - Tamworth
  • Riverina Cancer Care Centre - Wagga Wagga
  • Sydney Adventist Hospital - Wahroonga

South Australia

  • Royal Adelaide Hospital - Adelaide
  • Flinders Medical Centre - Bedford Park
  • The Queen Elizabeth Hospital - Woodville

Queensland

  • Royal Brisbane and Women's Hospital - Herston
  • Princess Alexandra - Woolloongabba

Michigan

  • Henry Ford Hospital - Detroit

New Hampshire

  • Dartmouth-Hitchcock - Lebanon

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 889 participants
Start Date 2009-06-02
Est. Completion 2030-12-15
Phase NA

Sponsor

Canadian Cancer Trials Group

16 total trials

What the Registry Record Tells You About NCT00819208

The ClinicalTrials.gov registry entry for NCT00819208 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 889 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 785-participant average among 679 other Depression trials with a reported enrollment target (13% higher). The listed sponsor is Canadian Cancer Trials Group, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Depression appearing as the primary indexed condition, and to 5 interventions - of which exercise intervention is the first listed.

NCT00819208 reports 20 study locations spanning 6 distinct geographic areas - top geographies include New South Wales, South Australia, Queensland.

Frequently Asked Questions

What is clinical trial NCT00819208 about?

NCT00819208 is a clinical study titled "Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer". RATIONALE: Participating in a physical activity program designed to increase free time physical activity and receiving written health education materials may influence the chance of cancer recurring as well as impact on physical fitness, psychological well-being and the quality of life of patients w...

What is the current status of trial NCT00819208?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 889 participants. The study started on 2009-06-02. Estimated completion is 2030-12-15.

What conditions does trial NCT00819208 study?

This clinical trial studies the following conditions: Depression, Colorectal Cancer, Fatigue, Anxiety Disorder, Sleep Disorders.

What interventions are being tested in trial NCT00819208?

The interventions under investigation include: exercise intervention (BEHAVIORAL), counseling intervention (OTHER), educational intervention (OTHER), laboratory biomarker analysis (OTHER), questionnaire administration (OTHER).

Who is sponsoring clinical trial NCT00819208?

This trial is sponsored by Canadian Cancer Trials Group, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00819208 being conducted?

This trial has 20 study locations across Michigan, New Hampshire, North Carolina, New South Wales, Queensland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.